Arax Advisory Partners’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.68K | Buy |
619
+567
| +1,090% | +$7.95K | ﹤0.01% | 2026 |
|
|
2025
Q1 | $813 | Buy |
52
+26
| +100% | +$406 | ﹤0.01% | 2375 |
|
|
2024
Q4 | $363 | Sell |
26
-718
| -97% | -$10K | ﹤0.01% | 2353 |
|
|
2024
Q3 | $6.92K | Sell |
744
-25
| -3% | -$233 | ﹤0.01% | 1565 |
|
|
2024
Q2 | $7.15K | Buy |
769
+759
| +7,590% | +$7.06K | ﹤0.01% | 1420 |
|
|
2024
Q1 | $99 | Sell |
10
-24
| -71% | -$238 | ﹤0.01% | 1290 |
|
|
2023
Q4 | $110 | Sell |
34
-14
| -29% | -$45 | ﹤0.01% | 1306 |
|
|
2023
Q3 | $255 | Hold |
48
| – | – | ﹤0.01% | 1272 |
|
|
2023
Q2 | $458 | Buy |
48
+6
| +14% | +$57 | ﹤0.01% | 1217 |
|
|
2023
Q1 | $462 | Buy |
42
+8
| +24% | +$88 | ﹤0.01% | 1202 |
|
|
2022
Q4 | $503 | Buy |
+34
| New | +$503 | ﹤0.01% | 1180 |
|